Comparing the Efficacy of Triamcinolone Acetonide Iontophoresis versus Topical Calcipotriol/Betamethasone Dipropionate in Treating Nail Psoriasis: A Bilateral Controlled Clinical Trial
Table 1
Mean severity score reduction during the course of study.
Treatment
Anatomical site
Mean severity score ± SD
P-value
Measurement number
0
1
2
3
4
5
6
Nail bed score
5.63 ± 3.59
5.63 ± 3.59
5.63 ± 3.59
5.06 ± 3.49
3.44 ± 2.68
1.94 ± 2.02
0.44 ± .89
< .001
TI
Matrix score
6.88 ± 8.16
6.88 ± 8.16
6.81 ± 8.1
6.13 ± 7.77
4.88 ± 7.06
4.31 ± 6.77
3.38 ± 5.91
.011
NAPSI
12.5 ± 6.31
12.5 ± 6.31
12.44 ± 6.3
11.19 ± 6.07
8.31 ± 5.9
6.25 ± 6.44
3.81 ± 5.86
< .001
Nail bed score
5.5 ± 3.5
5.5 ± 3.5
5.5 ± 3.5
5.38 ± 3.42
4.5 ± 3.37
2.5 ± 2.48
1 ± 1.71
< .001
CB
Matrix score
6.44 ± 8.49
6.44 ± 8.49
6.44 ± 8.49
6.38 ± 8.38
5.63 ± 7.56
4.88 ± 7.22
4.31 ± 6.81
.104
NAPSI
11.94 ± 6.42
11.94 ± 6.42
11.94 ± 6.42
11.75 ± 6.42
10.13 ± 5.84
7.38 ± 6.65
5.31 ± 6.68
< .001
TI: triamcinolone acetonide iontophoresis, CB: calcipotriol/betamethasone dipropionate, and SD: standard deviation.
